Literature DB >> 354517

Susceptibility of Canadida albicans to miconazole.

R M Bannatyne, R Cheung.   

Abstract

A total of 439 clinical isolates of Candida albicans were tested for susceptibility to miconazole by the agar dilution technique. When tests were read at 48 and 24 h, 56 and 84%, respectively, of the strains were completely inhibited by 4.0 mug of miconazole per ml, the estimated upper limit of probable clinical susceptibility.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 354517      PMCID： PMC352385          DOI： 10.1128/AAC.13.6.1040

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  6 in total

1.  Miconazole in the treatment of systemic fungal infections.

Authors:  D Stevens
Journal:  Am Rev Respir Dis       Date:  1977-11

2.  Miconazole, a broad-spectrum antimycotic agent with antibacterial activity.

Authors:  J M Van Cutsem; D Thienpont
Journal:  Chemotherapy       Date:  1972       Impact factor: 2.544

3.  In vitro studies with miconazole and miconazole nitrate.

Authors:  S Shadomy; L Paxton; A Espinel-Ingroff; H J Shadomy
Journal:  J Antimicrob Chemother       Date:  1977-03       Impact factor: 5.790

4.  Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester.

Authors:  P D Hoeprich; A C Huston
Journal:  J Infect Dis       Date:  1976-10       Impact factor: 5.226

Review 5.  Miconazole in coccidiodomycosis. II. Therapeutic and pharmacologic studies in man.

Authors:  D A Stevens; H B Levine; S C Deresinski
Journal:  Am J Med       Date:  1976-02       Impact factor: 4.965

6.  Miconazole in coccidioidomycosis. I. Assays of activity in mice and in vitro.

Authors:  H B Levine; D A Stevens; J M Cobb; A E Gebhardt
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226
  6 in total
  4 in total

Review 1.  Antifungal susceptibility tests.

Authors:  J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

Review 2.  Miconazole: a preliminary review of its therapeutic efficacy in systemic fungal infections.

Authors:  R C Heel; R N Brogden; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-01       Impact factor: 9.546

3.  Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B.

Authors:  D L Calhoun; G D Roberts; J N Galgiani; J E Bennett; D S Feingold; J Jorgensen; G S Kobayashi; S Shadomy
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

4.  In vitro activities of miconazole, miconazole nitrate, and ketoconazole alone and combined with rifampin against Candida spp. and Torulopsis glabrata recovered from cancer patients.

Authors:  M R Moody; V M Young; M J Morris; S C Schimpff
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.